Does presence of cribiform histology at biopsy in prostate cancer affect your management in an otherwise intermediate risk prostate cancer?  

There have been no trials on this specific question, so there is room for debate and more science (hoping our recent grant submission in this area gets funded...). Here is my current thinking. This is for generally healthy patients with long life expectancy (≥10 years but especially if ≥15 years...